Navigation Links
Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
Date:2/15/2011

ulated in DepoFoam, which is designed to address the limitations of widely used medications by enhancing their dosing and/or administration profile. Additional information about Pacira is available at www.pacira.com.

Any statements in this press release about our future expectations, plans and prospects, including statements about EXPAREL's potential, and other statements containing the words "believes," "anticipates," "plans," "expects," and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including risks relating to: our ability to successfully obtain regulatory approval for EXPAREL; our inability to obtain and maintain adequate protection for intellectual property rights relating to our product candidates and technologies; unplanned operating expenses and our ability to raise substantial additional funds to achieve our goals; general economic and industry conditions; and other factors discussed in the "Risk Factors" section of the final prospectus relating to our initial public offering filed with the Securities and Exchange Commission, and in other filings that we periodically make with the SEC. In addition, the forward-looking statements included in this press release represent our views as of the date of this press release. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.Contacts:James S. Scibetta, CFO, Pacira Pharmaceuticals, Inc.973-254-3560Jennifer Beugelmans, Inv
'/>"/>

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
2. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
3. Pacira Pharmaceuticals Announces FDA Acceptance of EXPAREL™ New Drug Application for Pain Management
4. Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment
5. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA)
6. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
7. ADVENTRX Pharmaceuticals Provides Update on ANX-514
8. Valeant Pharmaceuticals to Announce 2010 Fourth Quarter and Full Year Results on February 24, 2011
9. Conatus Pharmaceuticals Completes $20 Million Series B Private Placement Financing
10. Optimer Pharmaceuticals, Inc. Prices Public Offering of Common Stock
11. AcelRx Pharmaceuticals Announces Pricing of Its Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Massachusetts , May 23, 2013 ... Solutions™, announced today that the prize for ,Best Novel ... Systems and Medical Emergency Teams International Conference, hosted this ... Physicians, was awarded to a clinical research team studying ... at California Hospital in Los Angeles ...
(Date:5/23/2013)...  Inhibikase Therapeutics, Inc., an emerging leader in ... present new results on its antiviral program to ... the PML Consortium (composed of Pfizer, Bristol-Meyers Squibb, ... the causative agent of Progressive Multifocal Leukoencephalopathy (PML). ... extended release formulation, can clear JC polyomavirus (JCV) ...
(Date:5/23/2013)... May 23, 2013   BioLife Solutions , Inc. ... clinical grade hypothermic storage and cryopreservation ... contract aseptic media manufacturer , today announced its participation ... Medicine Congress 2013 this week in ... Dr. Aby J. Mathew, BioLife,s Senior Vice ...
Breaking Medicine Technology:Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 2Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 3Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 4Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3
(Date:5/23/2013)... May 23, 2013 Netsmart today ... 100 listing of healthcare information technology (HIT) providers for 2013. ... 2013 issue of Healthcare Informatics magazine. Netsmart’s ranking ... , “Our strong continued growth is largely due to our ... tumultuous period of healthcare where resources are scarce, the demand ...
(Date:5/23/2013)... Hormones drive many aspects of our lives: ... sleep quality, sex drive, how productive we are, soft skin ... driven by declining hormone levels as we age. , The ... abundant foundation or base from which the body makes hormones. ... about age 25, when we are “in our prime”; and ...
(Date:5/23/2013)... 23, 2013 Each month Dwell magazine ... stylish eco-friendly hybrids and electric cars. Nowhere in America are ... the symbolic green car capital. Thankfully this June, Green Car ... and drive back to Dwell on Design 2013 ... During the first two days of Dwell on Design, June ...
(Date:5/23/2013)... CNIC researchers have discovered that the daily clearance of ... stem cells from the bone marrow into the bloodstream, ... Cell ., Neutrophils are leukocytes (white blood cells) ... other disease organisms. To perform their function, these cells ... microorganisms. However, release of these substances in the wrong ...
(Date:5/23/2013)... May 23, 2013 Professional Insurance Plans, ... the nation to celebrate Fibromyalgia Education and Awareness Month. ... chiropractors across the country, the agency feels that it ... of this syndrome that affects an estimated 10 million ... Association , the definition of Fibromyalgia (FM) is, “a ...
Breaking Medicine News(10 mins):Health News:Netsmart Named to Healthcare Informatics Top 100 List 2Health News:Health2Go Announces Research That DHEA Helps Depression 2Health News:Health2Go Announces Research That DHEA Helps Depression 3Health News:Health2Go Announces Research That DHEA Helps Depression 4Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 2Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 3Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 4Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 5Health News:Discarded immune cells induce the relocation of stem cells 2Health News:Professional Insurance Plans Encourages the Nation to Celebrate Fibromyalgia Education and Awareness Month 2
... discussed at the 2009 AANS MeetingATLANTA, April 30 ... Annual Meeting, May 4-6 at the San Diego Convention ... latest line of stereotactic treatment solutions is addressing some ... today. Local Control of Brain Mets , Recent ...
... Mass., April 30 Alseres Pharmaceuticals, Inc. (Nasdaq: ... April 24, 2009 it entered into an Amendment to ... to which the license agreement between the Company and ... March 2007 (the Cethrin License) was further amended. ...
... Production of a Swine Flu Vaccine in a Few WeeksMERIDEN, Conn., ... based in Meriden, CT, announced today that stockholders elected a new ... 2009 Annual Meeting, held on April 28, 2009. Those Directors are:, ... Daniel D. Adams, who has been CEO since July 1996, President ...
... to address access to healthy food and physical ... exceptional leadership WASHINGTON, April 30 Eleven of ... a host of comprehensive policy strategies and environmental ... the childhood obesity epidemic. Their support will be ...
... Access to Nursing Home, Assisted Living, Home Care and Adult ... RICHMOND, Va., April 30 The cost of ... outpacing inflation, putting significant financial pressure on those in or ... At the same time, the current economic downturn has ...
... Home, Assisted Living, Home Care and Adult Day Health Care ... The cost of long term care in ... financial pressure on those in or near retirement, according to ... time, the current economic downturn has led to a decline ...
Cached Medicine News:Health News:Elekta Radiosurgery Solutions are Creating New Possibilities for the Most Challenging Cases of the Head And Body 2Health News:Elekta Radiosurgery Solutions are Creating New Possibilities for the Most Challenging Cases of the Head And Body 3Health News:Alseres and BioAxone Amend License Agreement for Cethrin(R) and Rho Inhibitor Technology 2Health News:Alseres and BioAxone Amend License Agreement for Cethrin(R) and Rho Inhibitor Technology 3Health News:Alseres and BioAxone Amend License Agreement for Cethrin(R) and Rho Inhibitor Technology 4Health News:Protein Sciences Corporation Appoints New Board of Directors 2Health News:Top Policy Groups Take Action to Create Healthy Communities, Prevent Childhood Obesity 2Health News:Top Policy Groups Take Action to Create Healthy Communities, Prevent Childhood Obesity 3Health News:Top Policy Groups Take Action to Create Healthy Communities, Prevent Childhood Obesity 4Health News:Growth in Wisconsin Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in Wisconsin Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in Wisconsin Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4Health News:Growth in Virginia Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in Virginia Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in Virginia Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4
... Western Blot analysis ... Blot Analyzer for many applications including the ... of infectious diseases such as viruses and ... screening of allergies and other application areas ...
... Antigen-Antibody Pens-Using a proprietary and patented technology, ... pens, called Antigen-Antibody pens-TM, that will allow ... membranes in any form or shape or ... helps to see antigen being written on ...
... the Antigen-Antibody Pens-Using a proprietary and patented ... fountain pens, called Antigen-Antibody pens-TM, that will ... blotting membranes in any form or shape ... dyes helps to see antigen being written ...
... the Antigen-Antibody Pens-Using a proprietary and patented ... fountain pens, called Antigen-Antibody pens-TM, that will ... blotting membranes in any form or shape ... dyes helps to see antigen being written ...
Medicine Products: